A detailed history of Alethea Capital Management, LLC transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Alethea Capital Management, LLC holds 427,454 shares of RNA stock, worth $13.4 Million. This represents 14.27% of its overall portfolio holdings.

Number of Shares
427,454
Previous 503,504 15.1%
Holding current value
$13.4 Million
Previous $20.6 Million 4.55%
% of portfolio
14.27%
Previous 15.72%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$37.21 - $48.14 $2.83 Million - $3.66 Million
-76,050 Reduced 15.1%
427,454 $19.6 Million
Q2 2024

Aug 15, 2024

SELL
$22.73 - $40.85 $5.85 Million - $10.5 Million
-257,193 Reduced 33.81%
503,504 $20.6 Million
Q1 2024

May 15, 2024

SELL
$9.16 - $25.52 $860,618 - $2.4 Million
-93,954 Reduced 10.99%
760,697 $19.4 Million
Q3 2023

Nov 14, 2023

BUY
$6.3 - $11.35 $31,500 - $56,750
5,000 Added 0.59%
854,651 $5.45 Million
Q1 2023

May 15, 2023

BUY
$15.35 - $25.65 $371,132 - $620,165
24,178 Added 2.93%
849,651 $13 Million
Q4 2022

Feb 14, 2023

SELL
$10.06 - $22.66 $100,600 - $226,600
-10,000 Reduced 1.2%
825,473 $18.3 Million
Q2 2022

Aug 15, 2022

SELL
$11.18 - $20.5 $609,131 - $1.12 Million
-54,484 Reduced 6.12%
835,473 $12.1 Million
Q1 2022

May 13, 2022

BUY
$14.2 - $23.78 $5,964 - $9,987
420 Added 0.05%
889,957 $16.4 Million
Q4 2021

Feb 14, 2022

SELL
$20.4 - $28.66 $367,812 - $516,739
-18,030 Reduced 1.99%
889,537 $21.1 Million
Q3 2021

Oct 27, 2021

SELL
$18.16 - $25.21 $4.71 Million - $6.53 Million
-259,180 Reduced 22.21%
907,567 $22.4 Million
Q2 2021

Aug 16, 2021

SELL
$19.62 - $29.26 $4.3 Million - $6.41 Million
-219,117 Reduced 15.81%
1,166,747 $28.8 Million
Q1 2021

May 14, 2021

SELL
$20.28 - $28.15 $3.76 Million - $5.22 Million
-185,296 Reduced 11.79%
1,385,864 $30.2 Million
Q4 2020

Feb 12, 2021

BUY
$24.73 - $35.12 $38.9 Million - $55.2 Million
1,571,160 New
1,571,160 $40.1 Million

Others Institutions Holding RNA

About Avidity Biosciences, Inc.


  • Ticker RNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,127,000
  • Market Cap $1.63B
  • Description
  • Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...
More about RNA
Track This Portfolio

Track Alethea Capital Management, LLC Portfolio

Follow Alethea Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alethea Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alethea Capital Management, LLC with notifications on news.